CVS Health Corp (NYSE:CVS) – Equities researchers at SunTrust Banks issued their Q1 2020 earnings per share (EPS) estimates for shares of CVS Health in a research report issued on Wednesday, April 10th. SunTrust Banks analyst D. Macdonald expects that the pharmacy operator will post earnings of $1.57 per share for the quarter. SunTrust Banks also issued estimates for CVS Health’s Q2 2020 earnings at $1.77 EPS, Q3 2020 earnings at $1.83 EPS, Q4 2020 earnings at $2.03 EPS and FY2020 earnings at $7.20 EPS.

Several other research analysts also recently weighed in on the company. BMO Capital Markets began coverage on CVS Health in a research note on Wednesday. They set a “market perform” rating and a $58.00 target price on the stock. Bank of America restated a “buy” rating and set a $82.00 target price on shares of CVS Health in a research note on Wednesday. Sanford C. Bernstein started coverage on CVS Health in a research note on Tuesday, March 12th. They set an “outperform” rating and a $76.00 target price on the stock. Citigroup lowered their price target on CVS Health from $94.00 to $68.00 and set a “buy” rating for the company in a research report on Wednesday, March 6th. Finally, ValuEngine cut CVS Health from a “sell” rating to a “strong sell” rating in a research report on Thursday, February 28th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $81.06.

Shares of CVS stock opened at $54.32 on Thursday. CVS Health has a 1-year low of $51.77 and a 1-year high of $82.15. The company has a current ratio of 1.03, a quick ratio of 0.65 and a debt-to-equity ratio of 1.22. The firm has a market cap of $69.75 billion, a P/E ratio of 7.67, a price-to-earnings-growth ratio of 1.04 and a beta of 0.94.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 20th. The pharmacy operator reported $2.14 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.07 by $0.07. CVS Health had a positive return on equity of 17.49% and a negative net margin of 0.31%. The firm had revenue of $54.42 billion for the quarter, compared to the consensus estimate of $53.78 billion. During the same period in the previous year, the business earned $1.92 EPS. The firm’s revenue for the quarter was up 12.5% on a year-over-year basis.

The company also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Shareholders of record on Tuesday, April 23rd will be given a dividend of $0.50 per share. The ex-dividend date is Monday, April 22nd. This represents a $2.00 dividend on an annualized basis and a yield of 3.68%. CVS Health’s dividend payout ratio is currently 28.25%.

In other news, COO Jonathan C. Roberts sold 77,639 shares of the business’s stock in a transaction dated Friday, February 1st. The stock was sold at an average price of $64.54, for a total value of $5,010,821.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director C David Brown II acquired 10,000 shares of the firm’s stock in a transaction dated Monday, March 11th. The stock was bought at an average cost of $53.18 per share, with a total value of $531,800.00. Following the acquisition, the director now owns 16,222 shares in the company, valued at $862,685.96. The disclosure for this purchase can be found here. In the last ninety days, insiders have acquired 23,600 shares of company stock valued at $1,270,896 and have sold 245,671 shares valued at $15,839,966. Insiders own 0.53% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Ferguson Wellman Capital Management Inc. acquired a new position in shares of CVS Health in the 1st quarter valued at about $267,000. Webster Bank N. A. lifted its holdings in shares of CVS Health by 21.5% in the 1st quarter. Webster Bank N. A. now owns 101,316 shares of the pharmacy operator’s stock valued at $5,464,000 after buying an additional 17,932 shares during the period. Old North State Trust LLC lifted its holdings in shares of CVS Health by 25.6% in the 1st quarter. Old North State Trust LLC now owns 4,313 shares of the pharmacy operator’s stock valued at $232,000 after buying an additional 879 shares during the period. Pacer Advisors Inc. acquired a new position in shares of CVS Health in the 1st quarter valued at about $6,228,000. Finally, North Star Investment Management Corp. lifted its holdings in shares of CVS Health by 13.0% in the 1st quarter. North Star Investment Management Corp. now owns 56,726 shares of the pharmacy operator’s stock valued at $3,059,000 after buying an additional 6,505 shares during the period. 81.62% of the stock is owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Further Reading: How the Consumer Price Index (CPI) is calculated?

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.